Vericel Reaffirms Full-year 2025 Profitability Guidance Of Gross Margin Of 74% And Adjusted EBITDA Margin Of 26%
Benzinga
Jul 31, 2025
2025 Financial Guidance
Reaffirmed MACI full-year revenue growth in the low 20% range
Updated Burn Care revenue guidance for the second half of 2025 to be in line with recent run rate of approximately $10 million per quarter
Reaffirmed full-year profitability guidance of gross margin of 74% and adjusted EBITDA margin of 26%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.